146 related articles for article (PubMed ID: 6320929)
1. Inhibition of the pentose phosphate shunt by lead: a potential mechanism for hemolysis in lead poisoning.
Lachant NA; Tomoda A; Tanaka KR
Blood; 1984 Mar; 63(3):518-24. PubMed ID: 6320929
[TBL] [Abstract][Full Text] [Related]
2. Hemolytic anemia in hereditary pyrimidine 5'-nucleotidase deficiency: nucleotide inhibition of G6PD and the pentose phosphate shunt.
Tomoda A; Noble NA; Lachant NA; Tanaka KR
Blood; 1982 Nov; 60(5):1212-8. PubMed ID: 6289944
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of the pentose phosphate shunt by 2,3-diphosphoglycerate in erythrocyte pyruvate kinase deficiency.
Tomoda A; Lachant NA; Noble NA; Tanaka KR
Br J Haematol; 1983 Jul; 54(3):475-84. PubMed ID: 6860590
[TBL] [Abstract][Full Text] [Related]
4. Hemolytic anemia in hereditary pyrimidine 5'-nucleotidase deficiency. II. Effect of pyrimidine nucleotides and their derivatives on glycolytic and pentose phosphate shunt enzyme activity.
Oda E; Oda S; Tomoda A; Lachant NA; Tanaka KR
Clin Chim Acta; 1984 Aug; 141(2-3):93-100. PubMed ID: 6091951
[TBL] [Abstract][Full Text] [Related]
5. Red cell metabolism in hereditary pyrimidine 5'-nucleotidase deficiency: effect of magnesium.
Lachant NA; Tanaka KR
Br J Haematol; 1986 Aug; 63(4):615-23. PubMed ID: 3015191
[TBL] [Abstract][Full Text] [Related]
6. Hemolytic anemias and erythrocyte enzymopathies.
Valentine WN; Tanaka KR; Paglia DE
Ann Intern Med; 1985 Aug; 103(2):245-57. PubMed ID: 2990276
[TBL] [Abstract][Full Text] [Related]
7. Effects of low-level lead exposure on pyrimidine 5'-nucleotidase and other erythrocyte enzymes. Possible role of pyrimidine 5'-nucleotidase in the pathogenesis of lead-induced anemia.
Paglia DE; Valentine WN; Dahlgren JG
J Clin Invest; 1975 Nov; 56(5):1164-9. PubMed ID: 1184742
[TBL] [Abstract][Full Text] [Related]
8. Effect of lead chelation therapy with EDTA in children on erythrocyte pyrimidine 5'-nucleotidase and with cytidine triphosphate levels.
Swanson MS; Angle CR; Stohs SJ
Int J Clin Pharmacol Ther Toxicol; 1982 Nov; 20(11):497-500. PubMed ID: 6293983
[TBL] [Abstract][Full Text] [Related]
9. Lead poisoning. Further observations on erythrocyte pyrimidine-nucleotidase deficiency and intracellular accumulation of pyrimidine nucleotides.
Paglia DE; Valentine WN; Fink K
J Clin Invest; 1977 Dec; 60(6):1362-6. PubMed ID: 915002
[TBL] [Abstract][Full Text] [Related]
10. Impaired pentose phosphate shunt function in sickle cell disease: a potential mechanism for increased Heinz body formation and membrane lipid peroxidation.
Lachant NA; Davidson WD; Tanaka KR
Am J Hematol; 1983 Aug; 15(1):1-13. PubMed ID: 6881134
[TBL] [Abstract][Full Text] [Related]
11. Response of erythrocyte pyrimidine 5'-nucleotidase (P5N) activity in workers exposed to lead.
Ichiba M; Tomokuni K
Br J Ind Med; 1988 Oct; 45(10):718-9. PubMed ID: 2848571
[No Abstract] [Full Text] [Related]
12. Inhibition of hexose monophosphate shunt in young erythrocytes by pyrimidine nucleotides in hereditary pyrimidine 5' nucleotidase deficiency.
David O; Ramenghi U; Camaschella C; Vota MG; Comino L; Pescarmona GP; Nicola P
Eur J Haematol; 1991 Jul; 47(1):48-54. PubMed ID: 1868914
[TBL] [Abstract][Full Text] [Related]
13. HPLC analysis of erythrocyte pyrimidine-5'-nucleotidase inhibition by lead.
Rocco RM; Smart JL; Brown DR; Blumberg JB
Res Commun Chem Pathol Pharmacol; 1981 Oct; 34(1):127-36. PubMed ID: 6273981
[TBL] [Abstract][Full Text] [Related]
14. [Glucose-6-phosphate dehydrogenase deficiency and other erythrocyte enzyme abnormalities].
Pohl A; Blechschmidt E; Moser K
Wien Klin Wochenschr; 1984 Jul; 96(14):542-8. PubMed ID: 6089445
[TBL] [Abstract][Full Text] [Related]
15. Lead poisoning: association with hemolytic anemia, basophilic stippling, erythrocyte pyrimidine 5'-nucleotidase deficiency, and intraerythrocytic accumulation of pyrimidines.
Valentine WN; Paglia DE; Fink K; Madokoro G
J Clin Invest; 1976 Oct; 58(4):926-32. PubMed ID: 965496
[TBL] [Abstract][Full Text] [Related]
16. Erythrocyte pyrimidine-5'-nucleotidase activity as a sensitive indicator of lead exposure.
Torrance JD; Mills W; Kilroe-Smith TA; Smith AN
S Afr Med J; 1985 May; 67(21):850-2. PubMed ID: 2986302
[TBL] [Abstract][Full Text] [Related]
17. A role of red cell pyrimidine 5'-nucleotidase in experimental lead poisoning.
Fujii H
Arch Toxicol; 1979 Oct; 43(1):59-64. PubMed ID: 231420
[TBL] [Abstract][Full Text] [Related]
18. Erythrocyte nucleotides from control and lead-treated rabbits.
Swanson MS; Angle CR; Stohs SJ; Rovang KS
Res Commun Chem Pathol Pharmacol; 1980 Feb; 27(2):353-61. PubMed ID: 6245437
[TBL] [Abstract][Full Text] [Related]
19. [Assessment of erythrocyte pyrimidine 5'-nucleotidase activity in the detection and early diagnosis of lead poisoning. A comparison with zinc-protoporphyrin].
Brunet M; Vives Corrons JL; Torra M; Rodamilans M; Pujades A; Corbella J; Pascual A
Med Clin (Barc); 1988 Oct; 91(14):521-4. PubMed ID: 2851079
[No Abstract] [Full Text] [Related]
20. Partial purification and properties of nicotinamide adenine dinucleotide synthetase from human erythrocytes: evidence that enzyme activity is a sensitive indicator of lead exposure.
Zerez CR; Wong MD; Tanaka KR
Blood; 1990 Apr; 75(7):1576-82. PubMed ID: 2107886
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
